Halozyme Therapeutics | Costo Del Venduto

Prezzo Delle Azioni
69.53
Cambio Giornaliero
0.31 0.45%
Mensile
-4.53%
Annuale
17.55%
Q1 Previsione
68.78




Costo Del Venduto Cambiamento Data
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 1.79B 128M 2025-12
Baxter International USD 2.4B 512M 2025-12
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 99.23M 13.32M 2025-09
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
MannKind USD 33.65M 13.44M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pfizer USD 6.29B 2.12B 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
United Therapeutics USD 474.7M 373.8M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Halozyme Therapeutics Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.